AI-Based Approach To Screen Opioid Receptor Ligands Via Grind Fingerprints and Convolutional Neural Network
DOI:
https://doi.org/10.31351/vol35iss2pp209-226Keywords:
Alignment-independent finger print GRIND, opioid virtual screening, convolutional neural networks, artificial intelligence , activity predictionAbstract
Opioid receptors belong to G-Protein Coupled Receptor (GPCR) family, and are divided into 3 subtypes of Mu, Kappa and Delta. The receptors are targeted by agonists and antagonists to manage variety of medical issues. Although main endogenous ligands for opioid receptors are peptides, a diverse set of non-peptide molecules can also bind orthosteric and allosteric sites of the receptor. Virtual screening for active agonists and antagonists using structure-based molecular docking is challenged by receptor flexibility, multimerization and orthosteric/allosteric sites coordination. Meanwhile, ligand-based virtual screening is more reliable. In this research grid-based alignment-independent molecular fingerprint (GRIND) and convolutional neural network (CNN) models are used to classify database of potential opioid ligands of experimentally measured activities. Six GRIND-CNN models were trained to recognize features within the fingerprint that are relevant to agonistic and antagonistic activities against each of Mu, Kappa and Delta receptors. The models performance measured by Area Under the Curve of Receiver Operating Characteristic (AUC-ROC), Matthews Correlation Coefficient (MCC) and Balanced Accuracy (BA). The GRIND-CNN models show mean AUC-ROC values (from 0.70 to 0.83) which are comparable to PubChem and Extended-connectivity fingerprints used for deep neural network (DNN) models (PubChem-DNN and ECFP-DNN, respectively. However, both of GRIND-CNN and PubChem-DNN models outperform ECFP-DNN model in recognition of activity-relevant features within relevant fingerprint (mean MCC values for Y-randomized training across all ligands groups are 0.05, 0.03 and 0.16, respectively). By using combined predictions of both GRIND-CNN and PubChem-DNN models with 0.5 coefficient for each, the mean AUC-ROC is improved (0.77 to 0.91) and MCC for Y-randomized training is reduced to 0.02, which indicates improved feature recognition. Saliency maps of GRIND fingerprints for models trained to differentiate agonists vs antagonists, and differentiate ligands vs non-ligands for different opioid receptor subtypes showed statically significant differences at correlogram bins (pixels) level. Such differences are related to message-address theory of opioid ligands. The research provides tools for virtual screening of opioid ligands that follow activity-relevant features recognition irrespective to molecular scaffold or size, in a manner similar to how a hand senses through distinct fingers the geometry of an object. The models are freely available on https://github.com/mohammednooraldeen/GRIND-CNN.
How to Cite
Publication Dates
Received
Revised
Accepted
Published Online First
References
Che T, Roth BL. Molecular basis of opioid receptor signaling. Cell. 2023;186(24):5203-19.
Hauser AS, Attwood MM, Rask-Andersen M, Schiöth HB, Gloriam DE. Trends in GPCR drug discovery: new agents, targets and indications. Nature reviews Drug discovery. 2017;16(12):829-42.
Sriram K, Insel PA. G Protein-Coupled Receptors as Targets for Approved Drugs: How Many Targets and How Many Drugs? Molecular pharmacology. 2018;93(4):251-8.
Stein C. Opioid Receptors. Annual Review of Medicine. 2016;67(Volume 67, 2016):433-51.
Zhang L, Zhang J-T, Hang L, Liu T. Mu Opioid Receptor Heterodimers Emerge as Novel Therapeutic Targets: Recent Progress and Future Perspective. Frontiers in Pharmacology. 2020;11.
Alananzeh WA, Al-Qattan MN, Ayipo YO, Mordi MN. N-substituted tetrahydro-beta-carboline as mu-opioid receptors ligands: in silico study; molecular docking, ADMET and molecular dynamics approach. Molecular diversity. 2024;28(3):1273-89.
Evers A, Hessler G, Matter H, Klabunde T. Virtual Screening of Biogenic Amine-Binding G-Protein Coupled Receptors: Comparative Evaluation of Protein- and Ligand-Based Virtual Screening Protocols. Journal of Medicinal Chemistry. 2005;48(17):5448-65.
Mahmod Al-Qattan MN, Mordi MN. Molecular Basis of Modulating Adenosine Receptors Activities. Current pharmaceutical design. 2019;25(7):817-31.
Bajusz D, Rácz A, Héberger K. 3.14 - Chemical Data Formats, Fingerprints, and Other Molecular Descriptions for Database Analysis and Searching. In: Chackalamannil S, Rotella D, Ward SE, editors. Comprehensive Medicinal Chemistry III. Oxford: Elsevier; 2017. p. 329-78.
Rogers D, Hahn M. Extended-connectivity fingerprints. J Chem Inf Model. 2010;50(5):742-54.
Durán Á, Zamora I, Pastor M. Suitability of GRIND-Based Principal Properties for the Description of Molecular Similarity and Ligand-Based Virtual Screening. Journal of Chemical Information and Modeling. 2009;49(9):2129-38.
Pastor M, Cruciani G, McLay I, Pickett S, Clementi S. GRid-INdependent Descriptors (GRIND): A Novel Class of Alignment-Independent Three-Dimensional Molecular Descriptors. Journal of Medicinal Chemistry. 2000;43(17):3233-43.
Tsou LK, Yeh SH, Ueng SH, Chang CP, Song JS, Wu MH, et al. Comparative study between deep learning and QSAR classifications for TNBC inhibitors and novel GPCR agonist discovery. Sci Rep. 2020;10(1):16771.
Mouhibi R, Zahouily M, El Akri K. Using multiple linear regression and artificial neural network techniques for predicting CCR5 binding affinity of substituted 1-(3, 3-Diphenylpropyl)-Piperidinyl amides and ureas. 2013.
Nguyen ATN, Nguyen DTN, Koh HY, Toskov J, MacLean W, Xu A, et al. The application of artificial intelligence to accelerate G protein-coupled receptor drug discovery. British Journal of Pharmacology. 2024;181(14):2371-84.
Liu S, Liu T, Gao L, Li H, Hu Q, Zhao J, et al. Convolutional Neural Network and Guided Filtering for SAR Image Denoising. Remote Sensing. 2019;11(6):702.
Kwon S, Bae H, Jo J, Yoon S. Comprehensive ensemble in QSAR prediction for drug discovery. BMC Bioinformatics. 2019;20(1):521.
Goh GB, Siegel C, Vishnu A, Hodas NO, Baker N. Chemception: a deep neural network with minimal chemistry knowledge matches the performance of expert-developed QSAR/QSPR models. arXiv preprint arXiv:170606689. 2017.
Hentabli H, Bengherbia B, Saeed F, Salim N, Nafea I, Toubal A, et al. Convolutional Neural Network Model Based on 2D Fingerprint for Bioactivity Prediction. International journal of molecular sciences. 2022;23(21).
Huo X, Xu J, Xu M, Chen H. An improved 3D quantitative structure-activity relationships (QSAR) of molecules with CNN-based partial least squares model. Artificial Intelligence in the Life Sciences. 2023;3:100065.
Shan W, Li X, Yao H, Lin K. Convolutional neural network-based virtual screening. Current Medicinal Chemistry. 2021;28(10):2033-47.
Munawar S, Windley MJ, Tse EG, Todd MH, Hill AP, Vandenberg JI, et al. Experimentally Validated Pharmacoinformatics Approach to Predict hERG Inhibition Potential of New Chemical Entities. Front Pharmacol. 2018;9:1035.
Ismatullah H, Jabeen I. Combined pharmacophore and grid-independent molecular descriptors (GRIND) analysis to probe 3D features of inositol 1, 4, 5-trisphosphate receptor (IP3R) inhibitors in cancer. International journal of molecular sciences. 2021;22(23):12993.
Khan HA, Jabeen I. Combined Machine Learning and GRID-Independent Molecular Descriptor (GRIND) Models to Probe the Activity Profiles of 5-Lipoxygenase Activating Protein Inhibitors. Frontiers in Pharmacology. 2022;13.
Shiri F, Pirhadi S, Ghasemi JB. Alignment independent 3D-QSAR, quantum calculations and molecular docking of Mer specific tyrosine kinase inhibitors as anticancer drugs. Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society. 2016;24(2):197-212.
Manouchehrizadeh E, Mostoufi A, Tahanpesar E, Fereidoonnezhad M. Alignment-independent 3D-QSAR and molecular docking studies of tacrine-4-oxo-4H-Chromene hybrids as anti-Alzheimer's agents. Computational biology and chemistry. 2019;80:463-71.
Moriwaki H, Tian YS, Kawashita N, Takagi T. Three-Dimensional Classification Structure-Activity Relationship Analysis Using Convolutional Neural Network. Chemical & pharmaceutical bulletin. 2019;67(5):426-32.
Bento AP, Hersey A, Félix E, Landrum G, Gaulton A, Atkinson F, et al. An open source chemical structure curation pipeline using RDKit. Journal of Cheminformatics. 2020;12(1):51.
Liu S, Alnammi M, Ericksen SS, Voter AF, Ananiev GE, Keck JL, et al. Practical Model Selection for Prospective Virtual Screening. Journal of Chemical Information and Modeling. 2019;59(1):282-93.
Sakamuru S, Zhao J, Xia M, Hong H, Simeonov A, Vaisman I, et al. Predictive Models to Identify Small Molecule Activators and Inhibitors of Opioid Receptors. Journal of Chemical Information and Modeling. 2021;61(6):2675-85.
Richardson E, Trevizani R, Greenbaum JA, Carter H, Nielsen M, Peters B. The receiver operating characteristic curve accurately assesses imbalanced datasets. Patterns (New York, NY). 2024;5(6):100994.
Qian X, Dai X, Luo L, Lin M, Xu Y, Zhao Y, et al. An Interpretable Multitask Framework BiLAT Enables Accurate Prediction of Cyclin-Dependent Protein Kinase Inhibitors. Journal of Chemical Information and Modeling. 2023;63(11):3350-68.
33. Lopez-del Rio A, Picart-Armada S, Perera-Lluna A. Balancing Data on Deep Learning-Based Proteochemometric Activity Classification. Journal of Chemical Information and Modeling. 2021;61(4):1657-69.
Fawcett T. An introduction to ROC analysis. Pattern Recognition Letters. 2006;27(8):861-74.
Chicco D, Tötsch N, Jurman G. The Matthews correlation coefficient (MCC) is more reliable than balanced accuracy, bookmaker informedness, and markedness in two-class confusion matrix evaluation. BioData Mining. 2021;14(1):13.
Fontaine F, Pastor M, Sanz F. Incorporating Molecular Shape into the Alignment-free GRid-INdependent Descriptors. Journal of Medicinal Chemistry. 2004;47(11):2805-15.
Shim J, Coop A, MacKerell AD, Jr. Molecular details of the activation of the μ opioid receptor. The journal of physical chemistry B. 2013;117(26):7907-17.
Kajino K, Tokuda A, Saitoh T. Morphinan Evolution: The Impact of Advances in Biochemistry and Molecular Biology. The Journal of Biochemistry. 2024;175(4):337-55.
Downloads
Published
License
Copyright (c) 2026 Iraqi Journal of Pharmaceutical Sciences

This work is licensed under a Creative Commons Attribution 4.0 International License.




